Value for money of changing healthcare services? Economic evaluation of quality improvement

被引:36
作者
Severens, JL [1 ]
机构
[1] Univ Maastricht, Univ Hosp Maastricht, Dept Hlth Org Policy & Econ, Dept Clin Epidemiol & MTA, NL-6200 MD Maastricht, Netherlands
来源
QUALITY & SAFETY IN HEALTH CARE | 2003年 / 12卷 / 05期
关键词
D O I
10.1136/qhc.12.5.366
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
There are many instances of perceived or real inefficiencies in health service delivery. Both healthcare providers and policy makers need to know the impact and cost of applying strategies to change the behaviour of individuals or organisations. Quality improvement or implementation research is concerned with evaluating the methods of behavioural change. Addressing inefficiencies in healthcare services raises a series of issues, beginning with how inefficiency itself should be defined. The basic concepts of cost analysis and economic evaluations are explained and a model for working through the economic issues of quality improvement is discussed. This model combines the costs and benefits of corrected inefficiency with the costs and degree of behavioural change achieved by a quality improvement method in the policy maker's locality. It shows why it may not always be cost effective for policy makers to address suboptimal behaviour. Both the interpretation of quality improvement research findings and their local application need careful consideration. The limited availability of applicable quality improvement research may make it difficult to provide robust advice on the value for money of many behavioural quality improvement strategies.
引用
收藏
页码:366 / 371
页数:6
相关论文
共 18 条
[1]   A COMPARISON OF RESULTS OF METAANALYSES OF RANDOMIZED CONTROL TRIALS AND RECOMMENDATIONS OF CLINICAL EXPERTS - TREATMENTS FOR MYOCARDIAL-INFARCTION [J].
ANTMAN, EM ;
LAU, J ;
KUPELNICK, B ;
MOSTELLER, F ;
CHALMERS, TC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (02) :240-248
[2]   Economic implications of non-compliance in health care [J].
Cleemput, I ;
Kesteloot, K .
LANCET, 2002, 359 (9324) :2129-2130
[3]   A clinical decision support system for prevention of venous thromboembolism - Effect on physician behavior [J].
Durieux, P ;
Nizard, R ;
Ravaud, P ;
Mounier, N ;
Lepage, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (21) :2816-2821
[4]   A randomized trial of Evidence-based OutReach (EBOR): Rationale and design [J].
Freemantle, N ;
Eccles, M ;
Wood, J ;
Mason, J ;
Nazareth, I ;
Duggan, C ;
Young, P ;
Haines, A ;
Drummond, M ;
Russell, I ;
Walley, T .
CONTROLLED CLINICAL TRIALS, 1999, 20 (05) :479-492
[5]  
Freemantle N, 2002, BRIT J GEN PRACT, V52, P290
[6]   The importance of achieving additional drug benefits at a reasonable cost - A review of the fluoxetine years [J].
Freemantle, N ;
Mason, J .
PHARMACOECONOMICS, 2000, 17 (04) :319-324
[7]  
FREEMANTLE N, 1996, EFFECTIVE PROFESSION
[8]  
Kaner EFS, 1999, BRIT J GEN PRACT, V49, P699
[9]  
LOBO CM, 2003, IN PRESS EUR J GEN P
[10]   When is it cost-effective to change the behavior of health professionals? [J].
Mason, J ;
Freemantle, N ;
Nazareth, I ;
Eccles, M ;
Haines, A ;
Drummond, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (23) :2988-2992